Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 1 | 3↑343.9% | 0↓96.0% | 0↑111.0% | 0 |
| Gross Profit | -0 | -8↓4127.9% | 0↑101.4% | -13↓11544.6% | -0↑99.8% |
| Operating Income | -3 | -15↓423.9% | -18↓22.8% | -20↓10.8% | -29↓42.3% |
| Net Income | -3 | -15↓419.2% | -18↓22.1% | -19↓5.4% | -28↓44.6% |
| EBITDA | 0 | 0 | -18 | -20↓10.3% | -27↓38.1% |
| EPS Diluted | -1.72 | -4.88↓183.7% | -4.26↑12.7% | -3.57↑16.2% | -1.16↑67.5% |